Clinical Trials Logo

Clinical Trial Summary

The Housing, Heating and Health Study has enrolled 409 households with ineffective heaters, who have a child with asthma between 6 and 12 years.

In the winter of 2005, houses were insulated and baseline measures taken of indoor temperatures, nitrogen dioxide, with more intensive indoor air quality monitoring in a sub-sample of 33 homes.

Objective data are being collected on the household’s health and energy usage. The households randomly assigned to the intervention group will have new heaters installed over the summer.

Results will be available after the follow-up data collection in 2006.


Clinical Trial Description

1. Introduction New Zealand houses are relatively poorly constructed and maintained for the temperate climate and most homes are heated to less than the WHO recommended minimum winter temperature of 18°C. Excess winter mortality is comparable to the levels in Portugal and Scotland. The Group’s previous Housing, Insulation and Health Study has shown that insulating existing homes leads to a small but significant improvement in health and energy consumption, but raised the question as to whether installing more sustainable heating could increase these gains.

2. Study design

We have enrolled 409 households, who use either plug-in electric heaters or unflued gas heating, and where there is a child with asthma, aged between 6 and 12 years. In the winter of 2005, uninsulated houses were insulated and baseline measures taken of indoor temperatures in the living room and the child’s bedroom, and levels of nitrogen dioxide. Intensive monitoring of indoor air quality is being carried out in a sub-sample of 33 homes. All members of the child’s family have filled out detailed questionnaires of their health and the heads-of -household have completed a questionnaire on the characteristics of the household’s energy usage. Objective measures are also being collected of the household’s fuel bills, the child’s attendance at school and the family’s health care utilisation.

Households are randomised so that the intervention group will have their choice of new, more efficient and sustainable heaters (heat pumps, wood pellet burners, or flued gas heaters) that heat more of the house and which emit no internal emissions installed over the summer. In the winter of 2006, follow-up measures will be taken and then the control households will receive their choice of new heaters. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT00489762
Study type Interventional
Source University of Otago
Contact
Status Completed
Phase N/A
Start date June 2005
Completion date October 2006

See also
  Status Clinical Trial Phase
Terminated NCT04410523 - Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma Phase 2
Completed NCT04624425 - Additional Effects of Segmental Breathing In Asthma N/A
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT03694158 - Investigating Dupilumab's Effect in Asthma by Genotype Phase 4
Terminated NCT04946318 - Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma Phase 2
Completed NCT04450108 - Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients N/A
Completed NCT03086460 - A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) Phase 2
Completed NCT01160224 - Oral GW766944 (Oral CCR3 Antagonist) Phase 2
Completed NCT03186209 - Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Phase 3
Completed NCT02502734 - Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Phase 3
Completed NCT01715844 - L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics Phase 1
Terminated NCT04993443 - First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 Phase 1
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT06033833 - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study Phase 2
Completed NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Phase 2
Completed NCT02212483 - Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Withdrawn NCT01468805 - Childhood Asthma Reduction Study N/A
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device